tert-Butyl 3-hydroxypyrrolidine-1-carboxylate

Catalog No. :
ACCSBW310
CAS No. :
103057-44-9
Molecular Formula :
C9H17NO3
Molecular Weight :
187.24

IUPAC Name:tert-Butyl 3-hydroxypyrrolidine-1-carboxylate

tert-Butyl 3-hydroxypyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$72.00Login to see priceIn stockInquiry
500g98%$354.00Login to see priceIn stockInquiry
1000g98%$567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-hydroxypyrrolidine-1-carboxylate
IUPAC Nametert-Butyl 3-hydroxypyrrolidine-1-carboxylate
Molecular FormulaC9H17NO3
Molecular Weight187.24
SMILESO=C(N1CC(O)CC1)OC(C)(C)C
InChI KeyAPCBTRDHCDOPNY-UHFFFAOYSA-N
Synonym3-HYDROXY-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;1-BOC-3-HYDROXYPYRROLIDINE;1-N-BOC-3-HYDROXY-PYRROLIDINE;N-BOC-3-HYDROXYPYRROLIDINE;N-(TERT-BUTOXYCARBONYL)-3-HYDROXYPYRROLIDINE;Tert-butyl 3-hydroxypyrrolidine-1-carboxylate;(S) 1-BOC-3-hydroxylpyrrolidine;3-Hydroxypyrrolidine, N-BOC protected
CAS No.103057-44-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACCSBW310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNE639 route compound structure diagram
    ACLRNE63934619-03-9 In Stock
  2. Plus
  3. ACBJUW016 route compound structure diagram
    ACBJUW01640499-83-0 In Stock
  4. Then
  5. ACCSBW310 route product structure diagram
    ACCSBW310103057-44-9 In Stock
Inquiry

2. ACCSBW310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQTLU531 route compound structure diagram
    ACQTLU53186953-79-9 In Stock
  2. Then
  3. ACCSBW310 route product structure diagram
    ACCSBW310103057-44-9 In Stock
Inquiry

Comments (0)